Byotrol gets boost from H1 results

AIM-listed infection control specialist Byotrol (LON:BYOT) saw its share price climb by 10.82% to 6.76p (as of 16:00 GMT) after reporting that sales for the six months to 30th September had tripled. The company also booked a pre-tax profit for the period rather than the loss recorded for the comparative half year during 2019.

Chairman John Langlands commented: “This was a very strong first half performance. The business has delivered sustainable profits, benefitting from our long term strategy and of course the significant demand for our infection control products arising from the COVID-19 pandemic. Our employees all delivered under very difficult circumstances as we faced restrictions in movement and shortages in raw materials.

“Byotrol remains extremely well positioned to benefit from the long term demand for infection control products both during and following the pandemic“.